The long term effect of inhaled hypertonic saline (6%) in non-cystic fibrosis bronchiectasis.

Category Primary study
Registry of TrialsANZCTR
Year 2007
INTERVENTION: Hypertonic saline (6%) ‐ 5mls nebulsied twice a day for 12 months CONDITION: Non‐cystic fibrosis bronchiechtasis PRIMARY OUTCOME: Pulmonary exacerbations SECONDARY OUTCOME: Antibiotic use Lung function Quality of life INCLUSION CRITERIA: Diagnosis of bronchiectasis using high resolution computer tomography (HRCT), at least two pulmonary exacerbations over past year, producing sputum daily, stable clinical state
Epistemonikos ID: ae2f2826031f58d9a198961e044d51d12a88cc00
First added on: Aug 25, 2024